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RESEARCH LETTER
Use of Ovulation Predictor Kits as Adjuncts When
Using Fertility Awareness Methods (FAMs): A Pilot
Study
Rene Leiva, MD, CM, CCFP, Ula Burhan, MSc, Edmond Kyrillos, MD, CCFP,
Richard Fehring, PhD, Robin McLaren, PhD, Catherine Dalzell, PhD,
and Elizabeth Tanguay, BSc
Purpose: Difficult clinical signs such as confusing cervical mucus or erratic basal body temperature can
make the use of fertility awareness methods (FAMs) difficult in some cases. The goal of this study was to
assess the feasibility of using a cheap urinary luteinizing hormone (LH)–surge identification kit as an
adjunct to identify the infertile phase after ovulation when facing these scenarios.
Methods: The study used a block-allocation, crossover, 2-arm methodology (LH kit/FAM vs FAM
only). Comparison of the 2 arms was done with regard to the accuracy of identification (yes/no) of the
luteal phase in each cycle as confirmed by serum progesterone concentrations.
Results: We recruited 23 Canadian women currently using FAM, aged 18 to 48 years, who have had
menstrual cycles 25 to 35 days long for the past 3 months and perceive themselves to have difficulty
with identifying the infertile phase after ovulation. LH kits identified 100% of the luteal phases, whereas
FAM indentified 87% (statistically significant). In those identified cycles, LH kits provided a mean of
10.3 days of infertility, and FAM only provided 10 days of infertility (not statistically significant).
Conclusions: Among this population, LH kits may offer an adjunct for women who may wish to have
an additional double-check. However, there are still clinical circumstances when even an LH kit does
not provide confirmation. More research in this area is encouraged. (J Am Board Fam Med 2014;27:
427–429.)
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Fertility awareness methods (FAMs) are effective
methods of family planning that make use of clin-
ical signs to monitor female fertility.1 They can
provide a valid option for women for whom other
methods are not desirable because of medical con-
traindications or environmental, philosophical, or
religious conﬂicts.
However, difﬁcult signs such as confusing cer-
vical mucus or erratic basal body temperature make
the use of these methods difﬁcult in some cases.
Thus new technological approaches are sought to
make FAMs easier, more effective, and cheaper.2
The purpose of this study was to assess the feasi-
bility of using a urinary luteinizing hormone (LH)–
surge identiﬁcation kit (sensitivity, 20 mIU/mL;
$1.00/kit; BTNX Inc., Toronto, ON, Canada) as
an adjunct to identify the infertile phase after ovu-
lation when facing challenging scenarios.
Methods
The study consisted of a block allocation, cross-
over, 2-arm methodology (Figure 1). We allocated
half of the participants to use the LH kit concur-
rently with a FAM during a menstrual cycle (arm
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1); subsequently, a cycle with a FAM-only method
was used (arm 2) (group A). The other half of
participants started with opposite sequence (group
B). Participants were allocated to one of the groups
depending on their order of enrollment into the
study. The main investigator (RL) ﬂipped a coin to
assign the ﬁrst participant to a speciﬁc group, and
the next participant was assigned to the alternate
group, and so on. Allocation assignment occurred
in similar pattern for each participant until enrol-
ment completed. This method was used to account
for a potential learning effect since each participant
was exposed to the 2 arms. Ethical approval for this
study was granted by the ethics and research boards
of the Ottawa Hospital and Bruyere Continuing
Care Hospital in Ottawa, Canada.
Each woman started once-a-day testing on the
sixth day following her ﬁrst day of menses until she
developed a surge in LH (ie, a positive result per
test’s instructions) and continuing until she re-
ceived negative results for 3 consecutive days. On
the third day following the last day of a positive
urine LH test, a serum progesterone test was done
to conﬁrm presence of the luteal phase (serum
progesterone concentration 10 nmol/L). In the
FAM-only cycles (arm 2), the participants pro-
ceeded with the progesterone test as soon as the
infertile phase occurred after ovulation, as deﬁned
by the FAM being used. The 2 arms were com-
pared with regard to accuracy of identiﬁcation (yes/
no) of the luteal phase. Statistical analysis to com-
pare the 2 arms consisted of creating a contingency
table and applying an exact McNemar test. Partic-
ipants trying to get pregnant or currently or re-
cently using (6 months) of any type of hormonal
contraception were excluded.
Results
Forty women were assessed for enrollment; 29 ful-
ﬁlled the criteria and 6 were lost to follow-up (loss
of interest, n  2; moved away, n  1; medical
reasons, n  3). The 23 women enrolled had the
following characteristics: age range 20 to 48 years;
Figure 1. Participants’ group allocation. Arm 1 included those using the luteinizing hormone kit and the fertility
awareness method (FAM), whereas arm 2 included those using only FAMs.
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mostly white (n  18); using mucus-based method
(n  14) or mucus temperature (n  9); all Cana-
dian; and all with a high school education or
higher.
Each woman supplied information on 2 cycles,
for a total of 46 cycles. Mean cycle length was 29.3
days. For the FAM cycles, mean length was 29 days.
For the cycles using LH kits, mean length was 29.5
days. There was no signiﬁcant difference between
cycle lengths for each woman. All the women cor-
rectly identiﬁed the luteal phase using the LH kit as
an adjunct. Three phases were not correctly iden-
tiﬁed using FAM only, giving a 0.13 absolute dif-
ference (Table 1). A mean of 15 kits were used per
cycle.
Discussion
In this pilot study, we found that the use of urinary
LH kits with a sensitivity of 20 mIU/mL may
provide a useful adjunct for those women with
difﬁculty identifying their postovulation period.
This study did not, however, attempt to develop a
new FAM method but to explore an option for
those women who need to gain extra conﬁdence.
There are a few limitations to our study. LH kits
may not provide a 100% conﬁrmation in clinical
circumstances outside our population of study
given the variability in the LH secretion during the
cycle3; such scenarios may include, for instance,
breastfeeding, very long anovulatory cycles, ex-
tremely short LH surges, and premenopause. In
addition, this study did not address the beginning
of the fertile phase, which still requires the use of a
reliable ﬁrst indicator for those women who do not
want to conceive. Theoretically, the above-men-
tioned problems could be easily addressed with the
development of simpler and cheaper urinary tests
or monitors that use the metabolites of estrogen
and progesterone.4 Future promising research
could involve the use of several urinary metabolites
(estradiol, LH, progesterone)2 with or without the
combination of clinical signs such as cervical mucus
to ascertain both the fertile and infertile phases of
the menstrual cycle. This pilot study could be used
as an example for future research.
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Table 1. Absolute and Relative Proportion of Detection between Luteinizing Hormone (LH) Adjunct and Fertility
Awareness Methods (FAMs)
Method Detected Cycles No. Proportion Relative Risk of FAM/LH (95% CI) Absolute Difference (LH  FAM)
FAM 20 23 0.87 0.87 (0.72–0.97) 0.13 (0.03–0.28)
LH kit/FAM 23 23 1.00
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